跳至主要内容
临床试验/NCT00741182
NCT00741182撤回2 期

Effect of PTH(1-34) Treatment on Fracture Healing in Vivo

Glostrup University Hospital, Copenhagen1 个研究点 分布在 1 个国家开始时间: 2008年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
发起方
试验地点
1
主要终点
Radiological evaluation of healing

研究概览

简要总结

The purpose of the study is to investigate, whether PTH(1-34) is able to promote fracture healing in postmenopausal women with fractures of the hip or shoulder.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 85 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Acute new osteoporotic trochanteric or collum chirurgicum fracture
  • Postmenopause

排除标准

  • Calcium metabolic disease other than osteoporosis
  • Diseases known to affect calcium homeostasis
  • Hypersensitivity to drug or other components of medication
  • pre-existing hypercalcemia
  • Decreased kidney function
  • Increased alkaline phosphatase
  • Prior external radiation therapy or brachytherapy of the skeleton
  • Skeletal malignancies or bone metastases
  • Alcohol and/or drug abuse
  • Systemic treatment with corticosteroids within the last four weeks
  • Non-cooperating patients
  • Patients who do not speak and understand the danish language

研究组 & 干预措施

Femur PTH(1-34)

Experimental

24 participants with trochanteric fractures will be assigned to Forsteo (PTH(1-34)) treatment

干预措施: rhPTH(1-34) (Drug)

Humerus PTH(1-34)

Experimental

24 participants with collum chirurgicum fracture will be assigned to Forsteo (PTH(1-34)) treatment

干预措施: rhPTH(1-34) (Drug)

结局指标

主要结局

Radiological evaluation of healing

时间窗: 0, 4, 8, 12, (16) weeks after fracture

次要结局

  • Biochemical bone markers(0, 1, 2, 3, 4, 8, 12, (16) weeks after fracture)
  • SF-36 questionnaire(0, 4, 8, 12, (16) weeks after fracture)

研究者

发起方
Glostrup University Hospital, Copenhagen
申办方类型
Other

研究点 (1)

Loading locations...

相似试验